mounjaro tirzepatide ordonnance france becomes first EU country to reimburse anti-obesity drugs Mounjaro sans ordonnance: achat, téléconsultation

Key Summary By the end of 2026, core patents on semaglutide will have expired in 10 countries, including Brazil, China, South Africa, Turkey and Canada

Further longer term studies of normal and genetically modified rodents are clearly warranted

Patients should prioritize the most important procedures and schedule those first before moving on to less critical ones

Wegovy is indicated for adults with an initial body mass index (BMI) of 30 kg/m (obesity), or 27 kg/m (overweight) in the presence of at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease